ウィメンズヘルスの世界市場レポート2024

ウィメンズヘルスの市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には5.6%の年間複合成長率（CAGR）で536億9,000万米ドルに成長すると予想されます。予測期間で予想される成長は、婦人科における精密医療の統合、女性に焦点を当てた臨床試験の増加、非侵襲的出生前検査の普及、不妊治療へのアクセスの拡大、精神的ケアの重要性の高まりに起因すると考えられます。 ウィメンズヘルスケアの健康。予測期間中に予想される主な動向には、デジタルヘルスソリューションの出現、生殖能力追跡とリプロダクティブヘルスのイノベーションの人気、非ホルモン避妊法の開発、母体の健康と妊娠モニタリングの進歩、ウィメンズヘルス診断のイノベーション、および統合が含まれます。人工知能（AI）の分野。

女性を中心とした病気の蔓延は、ウィメンズヘルス市場の成長軌道を推進する重要な原動力となっています。貧血、骨粗鬆症、乳がん、更年期障害などの疾患の急増は、家族歴、加齢、月経の早期開始や55歳以降の閉経、肥満などのさまざまな危険因子に起因すると考えられており、需要が高まっています。 ウィメンズヘルスの製品とサービスの場合。これらの製品は、女性の全体的な健康とウェルネスを優先しながら、これらの病気の治療に対応します。たとえば、2023年 1月に発表された米国がん協会の報告書では、子宮頸がんがアメリカ女性のがん関連死亡の主な原因として歴史的に位置づけられていることが強調されました。 2023年には米国で推定13,960人が新たに浸潤性子宮頸がんと診断され、約4,310人が死亡すると予想されています。したがって、女性中心の病気の発生率の増加が、ウィメンズヘルス市場の拡大の舵を切っています。

高齢化人口の急増は、ウィメンズヘルス市場の発展を推進する重要な触媒として現れています。 65歳以上の人口の割合が急増していることを特徴とする高齢化への人口動態の変化により、ウィメンズヘルスのニーズにさらに重点を置く必要があります。この層の女性は、骨粗鬆症、乳がん、更年期障害などの病気にかかる率が高くなります。この人口動態の変化は、特殊なウィメンズヘルスサービスおよび製品に対する需要の増大を浮き彫りにしています。これは、高齢ウィメンズヘルスを維持し、生活の質を向上させることを目的とした、予防措置、検査、および個別のヘルスケア介入の重要性を強調しています。特に、世界保健機関の2022年 10月の報告書は、2030年までに世界の6人に1人が60歳以上となり、60歳以上の人口は2050年までに倍増して21億人に達すると予測しています。したがって、高齢化人口の急増がウィメンズヘルス市場を大きく推進しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界のウィメンズヘルス市場、製品タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• デバイス
• 薬剤
• 医薬品パイプライン
• 世界のウィメンズヘルス市場、治療タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• ホルモン治療
• 非ホルモン治療
• 手術
• 世界のウィメンズヘルス市場、流通チャネル別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界のウィメンズヘルス市場、用途別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 閉経後骨粗鬆症
• ホルモン性不妊症
• 子宮内膜症と子宮筋腫
• 避妊薬
• 閉経
• 多嚢胞性卵巣症候群（PCOS）

第7章 地域および国の分析

• 世界のウィメンズヘルス市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
• 世界のウィメンズヘルス市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ウィメンズヘルス市場の競合情勢
• ウィメンズヘルス市場企業プロファイル
  • AbbVie Inc.
  • Bayer AG
  • Merck &Co Inc.
  • Pfizer Inc.
  • Agile Therapeutics

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

Women's Health Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on women's health market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for women's health? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The women's health market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Product Type: Devices; Drugs; Pharmaceutical Pipeline
• 2) By Age: 50 Years & above ; Other Ages
• 3) By Treatment Type: Hormonal Treatment; Non-Hormonal Treatment; Surgeries
• 4) By Application: Postmenopausal Osteoporosis; Hormonal Infertility; Endometriosis & Uterine Fibroids; Contraceptives; Menopause; Polycystic Ovary Syndrome (PCOS)
• 5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Companies Mentioned: AbbVie Inc.; Bayer AG; Merck & Co Inc.; Pfizer Inc.; Agile Therapeutics
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Women's health encompasses the medical field dedicated to the identification and management of ailments and conditions that affect both the physical and psychological well-being of women.

The primary categories of products related to women's health include devices, drugs, and pharmaceutical pipelines. Women's health devices are instrumental in treating medical conditions specific to women. This includes individuals aged 50 years and older, who may undergo hormonal treatment, non-hormonal treatment, and surgeries for a range of applications. These applications span postmenopausal osteoporosis, hormonal infertility, endometriosis, uterine fibroids, contraceptives, menopause, and polycystic ovary syndrome (PCOS). These women's health products are made available through various distribution channels, including hospitals, retail stores, and online pharmacies.

The women's health market research report is one of a series of new reports from The Business Research Company that provides women's health market statistics, including women's health industry global market size, regional shares, competitors with a women's health market share, detailed women's health market segments, market trends and opportunities, and any further data you may need to thrive in the women's health industry. This women's health market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The women's health market size has grown steadily in recent years. It will grow from $41.22 billion in 2023 to $43.24 billion in 2024 at a compound annual growth rate (CAGR) of 4.9%. The growth observed in the historical period can be attributed to several factors, including advancements in reproductive medicine, initiatives focused on awareness and education, empowerment and advocacy movements, advances in prenatal and postnatal care, and the development of hormone replacement therapies.

The women's health market size is expected to see strong growth in the next few years. It will grow to $53.69 billion in 2028 at a compound annual growth rate (CAGR) of 5.6%. The anticipated growth in the forecast period can be attributed to the integration of precision medicine in gynecology, an increase in female-focused clinical trials, the widespread adoption of non-invasive prenatal testing, expanded access to fertility treatments, and a growing emphasis on mental health in women's healthcare. Key trends expected during the forecast period include the emergence of digital health solutions, the popularity of fertility tracking and reproductive health innovations, the development of non-hormonal contraceptive options, advancements in maternal health and pregnancy monitoring, innovations in women's health diagnostics, and the integration of artificial intelligence (AI) in the field.

The escalating prevalence of women-centric diseases stands as a significant driver propelling the growth trajectory of the women's health market. A surge in conditions such as anemia, osteoporosis, breast cancer, menopause, and others, attributed to diverse risk factors like family history, advancing age, early onset of menstruation or menopause post-55 years, obesity, among others, is fueling the demand for women's health products and services. These offerings cater to treating these diseases while prioritizing the overall health and wellness of women. For example, the American Cancer Society's report published in January 2023 highlighted cervical cancer's historical status as a leading cause of cancer-related deaths among American women. An estimated 13,960 new cases of invasive cervical cancer are projected to be diagnosed in the USA in 2023, with approximately 4,310 anticipated fatalities. Hence, the escalating incidence of women-centric diseases is steering the expansion of the women's health market.

An upsurge in the aging populace emerges as a significant catalyst propelling the advancement of the women's health market. The demographic shift towards an aging population, characterized by a burgeoning proportion of individuals aged 65 and above, necessitates an increased focus on women's health needs. Women within this demographic encounter a higher prevalence of diseases such as osteoporosis, breast cancer, and menopause-related issues. This demographic shift underscores the augmented demand for specialized women's health services and products. It accentuates the significance of preventive measures, screenings, and tailored healthcare interventions aimed at preserving the well-being and enhancing the quality of life for older women. Notably, the World Health Organization's October 2022 report predicts that by 2030, 1 in 6 individuals globally will be aged 60 years or older, with the population of people aged 60 years and older anticipated to double by 2050, reaching 2.1 billion. Thus, the burgeoning aging population significantly propels the women's health market.

Innovations in women's health stand out as a prominent trend shaping the women's health market landscape. Leading companies in this sector are actively pursuing novel product developments to fortify their market presence. For instance, in November 2021, FemTec Health, a US-based startup specializing in women's health and beauty through technology and data-driven personalized care, introduced a pioneering data analytics platform named BiomeAI. This innovative platform utilizes genetic, consumer, microbiome, and biometric data to customize healthcare interventions for women. The BiomeAI engine harnesses deep machine learning and AI to translate this diverse data into tailored holistic healthcare strategies personalized for every individual woman.

Major players in the women's health market are integrating innovative technologies like Transcutaneous Electrical Nerve Stimulation (TENS) to solidify their position. TENS is a non-invasive therapeutic technique involving a battery-operated device that emits low-voltage electrical currents through electrode pads placed on specific body areas. This technology, exemplified by Myoovi's September 2023 launch in the UK, offers relief for painful menstruation cramps. By generating electrical signals, TENS interferes with and obstructs pain signals attempting to reach the brain, thereby minimizing pain. This drug-free alternative helps women manage the discomfort associated with menstrual cramps, offering a promising solution.

A notable strategic acquisitions, such as Partners Group's acquisition of Axia Women's Health in May 2021, play a pivotal role in shaping the women's health market. Partners Group, a global private equity firm based in Switzerland, expanded its portfolio in North American healthcare businesses through this acquisition. Axia Women's Health, a US-based women's healthcare services firm, operates within the women's health market, consolidating its offerings and expertise within the domain. This strategic move further solidifies the diverse landscape and comprehensive services available within the women's healthcare sector.

Major companies operating in the women's health market report are AbbVie Inc., Bayer AG, Merck & Co Inc., Pfizer Inc., Agile Therapeutics, Amgen Inc., Apothecus Pharmaceutical Corporation, Blairex Laboratories Inc., Novartis AG, AstraZeneca PLC, F. Hoffmann-La Roche Ltd., Ferring Pharmaceuticals, Lupin Pharmaceuticals Inc., Johnson & Johnson Services Inc., Allergan PLC, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Siemens AG, Hologic Inc., Celmatix Inc., HERA Biotech Inc., Juno Bio Inc., Maven Clinic Inc., MobileODT Ltd., Mylan N.V., ObsEva SA, Oviva Therapeutics Inc., Samphire Neuro Inc., Scailyte AG, Syrona Health AG

North America was the largest region in the women's health market in 2023. Asia-Pacific is expected to be the fastest-growing region in the women's health market report during the forecast period. The regions covered in the women's health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the women's health market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The women's health market consists of revenues earned by entities by providing hormone therapy, birth control treatment, and other related services. The market value includes the value of related goods sold by the service provider or included within the service offering. The women's health market also includes sales of contraceptive devices and pharmaceuticals, densitometry, breast implants, obstetrics or gynecology biopsy, imaging devices, and drugs such as Xgeva, Evista, Mirena, Zometa, Reclast, and Class, among others, that are used in providing women's health services. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Women's Health Market Characteristics

3. Women's Health Market Trends And Strategies

4. Women's Health Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Women's Health Market Size and Growth

• 5.1. Global Women's Health Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Women's Health Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Women's Health Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Women's Health Market Segmentation

• 6.1. Global Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Devices
• Drugs
• Pharmaceutical Pipeline
• 6.2. Global Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hormonal Treatment
• Non-Hormonal Treatment
• Surgeries
• 6.3. Global Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.4. Global Women's Health Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Postmenopausal Osteoporosis
• Hormonal Infertility
• Endometriosis & Uterine Fibroids
• Contraceptives
• Menopause
• Polycystic Ovary Syndrome (PCOS)

7. Women's Health Market Regional And Country Analysis

• 7.1. Global Women's Health Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Women's Health Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Women's Health Market

• 8.1. Asia-Pacific Women's Health Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Women's Health Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Women's Health Market

• 9.1. China Women's Health Market Overview
• 9.2. China Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Women's Health Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Women's Health Market

• 10.1. India Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Women's Health Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Women's Health Market

• 11.1. Japan Women's Health Market Overview
• 11.2. Japan Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Women's Health Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Women's Health Market

• 12.1. Australia Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Women's Health Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Women's Health Market

• 13.1. Indonesia Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Women's Health Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Women's Health Market

• 14.1. South Korea Women's Health Market Overview
• 14.2. South Korea Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Women's Health Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Women's Health Market

• 15.1. Western Europe Women's Health Market Overview
• 15.2. Western Europe Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Women's Health Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Women's Health Market

• 16.1. UK Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Women's Health Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Women's Health Market

• 17.1. Germany Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Women's Health Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Women's Health Market

• 18.1. France Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Women's Health Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Women's Health Market

• 19.1. Italy Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Women's Health Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Women's Health Market

• 20.1. Spain Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Women's Health Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Women's Health Market

• 21.1. Eastern Europe Women's Health Market Overview
• 21.2. Eastern Europe Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Women's Health Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Women's Health Market

• 22.1. Russia Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Women's Health Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Women's Health Market

• 23.1. North America Women's Health Market Overview
• 23.2. North America Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Women's Health Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Women's Health Market

• 24.1. USA Women's Health Market Overview
• 24.2. USA Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Women's Health Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Women's Health Market

• 25.1. Canada Women's Health Market Overview
• 25.2. Canada Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Women's Health Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Women's Health Market

• 26.1. South America Women's Health Market Overview
• 26.2. South America Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Women's Health Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Women's Health Market

• 27.1. Brazil Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Women's Health Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Women's Health Market

• 28.1. Middle East Women's Health Market Overview
• 28.2. Middle East Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Women's Health Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Women's Health Market

• 29.1. Africa Women's Health Market Overview
• 29.2. Africa Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Women's Health Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Women's Health Market Competitive Landscape And Company Profiles

• 30.1. Women's Health Market Competitive Landscape
• 30.2. Women's Health Market Company Profiles
  • 30.2.1. AbbVie Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Bayer AG
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Merck & Co Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Pfizer Inc.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Agile Therapeutics
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Women's Health Market Competitive Benchmarking

32. Global Women's Health Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Women's Health Market

34. Women's Health Market Future Outlook and Potential Analysis

• 34.1 Women's Health Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Women's Health Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Women's Health Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer